R9-6-408. Termination from ADAP Services

A. The Department may terminate an enrolled individual’s enrollment in ADAP if: 1. The Department learns that information submitted to the Department by the enrolled individual or the enrolled individual’s representative under R9-6-404(A) or (C), R9-6-407(A), or R9-6-409(E) or (F) is inaccurate or incomplete; 2. The enrolled individual or the enrolled individual’s representative does not request a refill of any drug through ADAP for a period of 90 calendar days; or 3. The enrolled individual or the enrolled individual’s representative exhibits violent or threatening behavior to an employee of the Department, the contract pharmacy, or a pharmacy in which the enrolled individual or the enrolled individual’s representative is filling a prescription for a drug or requesting a refill of a drug through ADAP, as established by documentation such as a police report or a written document from the individual. B. The Department may terminate approval of a drug approved under R9-6-409(E) or (F) for an enrolled individual if funding is no longer available to pay for the drug approved under R9- 6-409(E) or (F). C. The Department shall send to an enrolled individual or the enrolled individual’s representative a written notice of termination setting forth the information required under A.R.S. § 41-1092.03 if the Department terminates: 1. The enrolled individual’s enrollment in ADAP, or 2. Approval of a drug approved under R9-6-409(E) or (F) for the enrolled individual.